Hidradenitis suppurativa
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
Hidradenitis suppurativa (ogbo I) n'ime ogwe aka. Nke a bụ ikpe dị nro nke Hidradenitis suppurativa.
References
Hidradenitis suppurativa bụ ọrịa akpụkpọ ahụ nke na-adịghị ala ala, na-alọghachi azụ, ma nwee ike imetụta ndụ gị nke ukwuu. Ọ na-ebute ya site na mbufụt na ntutu isi, ọ na-ebutekarịkwa ọrịa nje. Ndị dọkịta na-achọpụtakarị ya site n'ileba anya n'ụdị ọnyá ị nwere (dị ka nodules, abscesses, ma ọ bụ traktị sinus) , ebe ha nọ (na-emekarị na akpụkpọ anụ) , na ugboro ole ha na-alọghachi na ogologo oge ha na-arapara n'ahụ.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
A na-ejikarị ọgwụgwọ ndị na-abụghị nke usoro ndu na ndị na-abụghị nke usoro eme ihe maka ọrịa dị nro ma nwee ike jikọta ya na ọgwụgwọ usoro ndu na ịwa ahụ maka ọrịa na-agafeghị oke ruo nke siri ike. Ọmụmụ ihe na-adịbeghị anya na-enyekwu ihe akaebe nke ịdị irè maka iji corticosteroids gbanyere ozugbo n'ime ọnya maka ọkụ ọkụ HS na ọnya mpaghara. Ọzọkwa, enwere ihe akaebe na-egosi na iji tetracyclines naanị nwere ike ịdị irè dịka ijikọ clindamycin na rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
A na-eji ọtụtụ ọgwụgwọ maka hidradenitis suppurativa, gụnyere ọgwụ nje, retinoids, antiandrogens, ọgwụ ndị na-egbochi mgbochi, ọgwụ mgbochi mkpali, na redio ọgwụgwọ maka ọnya mbụ. Ọgwụgwọ kachasị akwadoro bụ adalimumab na ọgwụgwọ laser. Ịwa ahụ, ma ọ bụ mpụ dị mfe ma ọ bụ mpụpụ zuru oke na mpaghara site na iji grafting akpụkpọ ahụ, bụ nhọrọ kachasị mma maka ikpe siri ike, nke dị elu nke na-adịghị anabata ọgwụgwọ ndị ọzọ.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
A naghị edokarị ihe kpatara ya, mana ekwenyere na ọ gụnyere nchikota mkpụrụ ndụ ihe nketa na ihe gburugburu ebe obibi. Ihe dị ka otu ụzọ n'ụzọ atọ nke ndị nwere ọrịa ahụ nwere onye òtù ezinụlọ emetụtara. Ihe ndị ọzọ dị ize ndụ gụnyere oke ibu na ise siga. Ọ bụghị ọrịa kpatara ọnọdụ a, adịghị ọcha.
Ọ dịghị ọgwụgwọ a ma ama. Ịcha imeghe ọnya ahụ iji mee ka ha gbasaa adịghị arụpụta uru dị ukwuu. Ọ bụ ezie na a na-ejikarị ọgwụ nje eme ihe, ihe àmà maka ojiji ha adịghị mma. Enwere ike ịnwale ọgwụ mgbochi mgbochi. N'ime ndị nwere ọrịa ka njọ, ọgwụgwọ laser ma ọ bụ ịwa ahụ iji wepụ akpụkpọ ahụ emetụtara nwere ike ịdị irè. Ọ dị obere, ọnya akpụkpọ ahụ nwere ike ịmalite ịghọ ọrịa kansa anụ ahụ.
Ọ bụrụ na agụnyere okwu dị nro nke hidradenitis suppurativa , mgbe ahụ, atụmatụ nke ugboro ya sitere na 1-4% nke ndị bi na ya. Ụmụ nwanyị dị okpukpu atọ ka a ga-achọpụta ya karịa ụmụ nwoke. Mmalite na-abụkarị n'oge ntorobịa.